Development asset linked to First Biotech (Australia) in public FDA and regional records.
pharma · Dry Eye Disease
First Biotech (Australia)
Alcon Laboratories (Australia) Pty Ltd
First Biotech (Australia) drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Melbourne, AU HQ
2017 Founded
2 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Melbourne, AU
- Founded
- 2017
- Employees
- 2
- Programs
- 1
- Drugs
- 4
- Patents
- 0
First Biotech (Australia) pipeline
Portfolio lens on 4 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
First Biotech (Australia) drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
US regulatory status: approved.
-
Development asset linked to First Biotech (Australia) in public FDA and regional records.
-
Development asset linked to First Biotech (Australia) in public FDA and regional records.